Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma

NCT01355705 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Amrubicin
DRUG: Lenalidomide
DRUG: Dexamethasone
DRUG: Aspirin
DRUG: Pegfilgrastim

Sponsor

Michaela Liedtke

Collaborators

[object Object]